Corona Vaccins First Dose Efficacy

From Tech
Revision as of 12:12, 11 July 2021 by Joosteto (talk | contribs) (→‎AstraZeneca)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search

Pfizer

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (BNT162b2=Pfizer/BioNTech)

Efficacy of BNT162b2 (Pfizer) against Covid-19 after the First Dose.

Vaccinated vs Unvaccinated in BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Vaccinated vs Unvaccinated in BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Moderna

Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020

Cumulative Incidence Curves for the First COVID-19 Occurrence After Randomization, mITT Set

AstraZeneca

Cumulative incidence plot for time to first SARS-CoV-2 virologically-confirmed COVID-19 occurring post dose1


Screenshot 2021-07-11 at 13-07-32 Public Assessment Report - UKPAR COVID 19 Vaccine AstraZeneca 23 02 2021 pdf.png

(Oxford/AstraZeneca COVID-19 vaccine AZD1222)

Retrieved from "http://tech.komputilo.org/index.php?title=Corona_Vaccins_First_Dose_Efficacy&oldid=714"

Navigation menu

Page actions

  • Page
  • Discussion
  • View source
  • History

Page actions

  • Page
  • Discussion
  • More
  • Tools
  • In other languages

Personal tools

  • Log in

Navigation

  • Main page
  • Recent changes
  • Random page
  • Help about MediaWiki

 

Tools

  • What links here
  • Related changes
  • Special pages
  • Printable version
  • Permanent link
  • Page information
GNU Free Documentation License 1.2
Powered by MediaWikiPowered by Debian
  • This page was last edited on 11 July 2021, at 15:18.
  • Content is available under GNU Free Documentation License 1.2 unless otherwise noted.
  • Privacy policy
  • About Tech
  • Disclaimers